Origin
AI and Data for Cancer Therapeutics
We produce patient-derived cancer datasets for licensing to pharmaceutical and AI companies. Our data comprises matched spatial transcriptomics, H&E and clinical labels. We operate our own laboratory, where samples are processed. Samples are sourced from leading biobank / hospital networks. As R&D workflows increasingly rely on frontier AI systems, we believe there is critical need for real world datapoints so that findings translate in the clinic.
- Website
- origin.bio
- City
- San Francisco
- Country
- United States
- YC batch
- Winter 2026
- Team
- 8 people
- Stage
- Early stage
- AI-native
- Yes
- Hiring
- Open roles
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run origin.bio and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Origin across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Origin's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
